PMID- 25400545 OWN - NLM STAT- PubMed-not-MEDLINE DCOM- 20141117 LR - 20200930 IS - 1662-5099 (Print) IS - 1662-5099 (Electronic) IS - 1662-5099 (Linking) VI - 7 DP - 2014 TI - A transgenic mouse line for collecting ribosome-bound mRNA using the tetracycline transactivator system. PG - 82 LID - 10.3389/fnmol.2014.00082 [doi] LID - 82 AB - Acquiring the gene expression profiles of specific neuronal cell-types is important for understanding their molecular identities. Genome-wide gene expression profiles of genetically defined cell-types can be acquired by collecting and sequencing mRNA that is bound to epitope-tagged ribosomes (TRAP; translating ribosome affinity purification). Here, we introduce a transgenic mouse model that combines the TRAP technique with the tetracycline transactivator (tTA) system by expressing EGFP-tagged ribosomal protein L10a (EGFP-L10a) under control of the tetracycline response element (tetO-TRAP). This allows both spatial control of EGFP-L10a expression through cell-type specific tTA expression, as well as temporal regulation by inhibiting transgene expression through the administration of doxycycline. We show that crossing tetO-TRAP mice with transgenic mice expressing tTA under the Camk2a promoter (Camk2a-tTA) results in offspring with cell-type specific expression of EGFP-L10a in CA1 pyramidal neurons and medium spiny neurons in the striatum. Co-immunoprecipitation confirmed that EGFP-L10a integrates into a functional ribosomal complex. In addition, collection of ribosome-bound mRNA from the hippocampus yielded the expected enrichment of genes expressed in CA1 pyramidal neurons, as well as a depletion of genes expressed in other hippocampal cell-types. Finally, we show that crossing tetO-TRAP mice with transgenic Fos-tTA mice enables the expression of EGFP-L10a in CA1 pyramidal neurons that are activated during a fear conditioning trial. The tetO-TRAP mouse can be combined with other tTA mouse lines to enable gene expression profiling of a variety of different cell-types. FAU - Drane, Laurel AU - Drane L AD - Department of Neuroscience, School of Medicine, Tufts University Boston, MA, USA ; Graduate Program in Neuroscience, Sackler School of Graduate Biomedical Sciences, Tufts University Boston, MA, USA. FAU - Ainsley, Joshua A AU - Ainsley JA AD - Department of Neuroscience, School of Medicine, Tufts University Boston, MA, USA. FAU - Mayford, Mark R AU - Mayford MR AD - Department of Molecular and Cellular Neuroscience, The Scripps Research Institute La Jolla, CA, USA. FAU - Reijmers, Leon G AU - Reijmers LG AD - Department of Neuroscience, School of Medicine, Tufts University Boston, MA, USA. LA - eng GR - R01 MH057368/MH/NIMH NIH HHS/United States GR - R21 MH099794/MH/NIMH NIH HHS/United States GR - DP2 OD006446/OD/NIH HHS/United States GR - P30 NS047243/NS/NINDS NIH HHS/United States GR - T32 NS061764/NS/NINDS NIH HHS/United States PT - Journal Article DEP - 20141029 PL - Switzerland TA - Front Mol Neurosci JT - Frontiers in molecular neuroscience JID - 101477914 PMC - PMC4212621 OTO - NOTNLM OT - CA1 pyramidal neuron OT - Camk2a OT - Fos OT - TRAP OT - tetracycline transactivator EDAT- 2014/11/18 06:00 MHDA- 2014/11/18 06:01 PMCR- 2014/01/01 CRDT- 2014/11/18 06:00 PHST- 2014/08/15 00:00 [received] PHST- 2014/10/08 00:00 [accepted] PHST- 2014/11/18 06:00 [entrez] PHST- 2014/11/18 06:00 [pubmed] PHST- 2014/11/18 06:01 [medline] PHST- 2014/01/01 00:00 [pmc-release] AID - 10.3389/fnmol.2014.00082 [doi] PST - epublish SO - Front Mol Neurosci. 2014 Oct 29;7:82. doi: 10.3389/fnmol.2014.00082. eCollection 2014.